Tardive Dyskinesia (TD) is a neurological movement disorder typically characterized by repetitive, involuntary movements of the jaw, lips, and tongue....
Pompe disease is estimated at 1 in every 40,000 births. It is a rare, inherited disorder caused by the buildup of a complex sugar called glycogen and...
Orsini Specialty Pharmacy, the leading independent specialty pharmacy focused on rare diseases and gene therapies, announced today that Sanofi has...
Orsini is a leading independent national specialty pharmacy accredited by ACHC, JCAHO, URAC, and VIPPS. The services we provide allow patients, physicians, payors, and manufacturers to improve care, simplify processes, and achieve better outcomes.
Payor Considerations When Evaluating a Specialty Pharmacy Partner
Choosing a Specialty Pharmacy to Support Tardive Dyskinesia Patients
Orsini Specialty Pharmacy Selected by Provention Bio as a Limited Distribution Partner for TZIELD
Choosing a Specialty Pharmacy to Support Mucopolysaccharidosis (MPS) Patients
Orsini Salutes Healthcare Quality Week
.jpg?width=1754&name=SP_Logo_Color_RGB%202020update%20(1).jpg "Orsini Specialty Pharmacy Logo"){kind=logo}
![[Whitepaper] Payor Considerations When Choosing a Specialty Pharmacy](https://no-cache.hubspot.com/cta/default/7642930/d6329582-47a1-404d-b2a8-63c2637a9807.png)